Quicking Biotech Co., Ltd., founded in 2006, has established itself as a premier provider of rapid diagnostic solutions for a wide range of applications, including clinical diagnostics, food safety, and veterinary testing. The company’s mission is to deliver innovative, reliable, and affordable diagnostic tools that enhance global healthcare accessibility. With a strong global presence, Quicking Biotech exports its products to over 100 countries, serving hospitals, laboratories, clinics, and public health organizations. The company’s headquarters and state-of-the-art manufacturing facilities are located in Shanghai, China, where a dedicated team of researchers and technicians continuously develop new diagnostic technologies. By focusing on precision and speed, Quicking Biotech addresses the growing demand for point-of-care testing that delivers accurate results in minutes. The organization also emphasizes rigorous quality assurance, holding ISO 13485 and CE certifications that underline its commitment to international standards. Through partnerships and distribution networks, the company ensures that its diagnostic products reach even the most remote areas, supporting disease surveillance and outbreak control. Quicking Biotech’s reputation as a leader in the in vitro diagnostics (IVD) sector is built on decades of experience and a customer-centric approach that prioritizes reliability over shortcuts. In an era where timely diagnosis can save lives, Quicking Biotech stands at the forefront of molecular diagnostics and rapid testing innovation.

Quicking Biotech offers a comprehensive portfolio of rapid test kits designed to detect a variety of infectious diseases, including COVID-19, HIV, malaria, dengue, and hepatitis B and C. Each product is engineered for high sensitivity and specificity, ensuring that healthcare providers can trust the results for critical decision-making. The company also produces tests for drugs of abuse, pregnancy, and tumor markers, making its catalog one of the most versatile in the diagnostic industry. All kits are based on immunochromatographic assay technology, which allows for simple, visual readout without the need for expensive equipment. For example, a single COVID-19 antigen test from Quicking can deliver results in 10-20 minutes, enabling rapid triage and isolation. The HIV test kit is widely used in community screening programs because of its ease of use and long shelf life. Malaria rapid tests are particularly valuable in tropical regions where access to microscopy is limited. Additionally, Quicking Biotech offers food safety kits that screen for pathogens like Salmonella and E. coli, demonstrating the company's expansion beyond human diagnostics. Every product in the line undergoes extensive validation to comply with global regulatory standards, ensuring consistent performance across different environmental conditions. By integrating sonograms and other imaging data with biochemical markers, Quicking Biotech continues to push the boundaries of what rapid tests can achieve. The product line is continuously updated to address emerging health threats, reflecting the company’s proactive approach to public health.

The diagnostic solutions provided by Quicking Biotech offer several distinct advantages that set them apart from competitors in the IVD market. First and foremost, the kits exhibit high sensitivity and specificity, often exceeding 98% for major targets like COVID-19 and HIV, which reduces false negatives and false positives. Rapid turnaround time is another critical benefit: most tests provide clear results within 10-20 minutes, allowing for immediate clinical action without waiting hours or days. This speed is particularly crucial in emergency settings, where every minute counts. Furthermore, all Quicking products carry CE certification and ISO 13485 accreditation, giving users confidence in the manufacturing quality and regulatory compliance. Cost‑effectiveness is a deliberate design principle: the kits are priced to be accessible in low‑resource environments, enabling widespread use in developing nations. The simplicity of the test procedure means that minimal training is required, and results can be interpreted by non‑laboratory personnel. Quicking Biotech also invests heavily in diagnostic imaging research, integrating advanced markers that improve the detection of co‑infections. For instance, a multiplex rapid test can simultaneously screen for malaria, dengue, and leptospirosis, saving time and resources. These advantages collectively ensure that Quicking diagnostics are not only accurate but also practical for real‑world deployment, from remote field clinics to busy urban hospitals.

Quicking Biotech operates a 10,000-square-meter manufacturing facility that adheres to Good Manufacturing Practice (GMP) standards, ensuring that every batch of diagnostic kits meets stringent quality requirements. The production process begins with raw material screening, where antibodies and antigens are tested for purity and reactivity before entering the assembly line. Each step is monitored by automated systems that record temperature, humidity, and pressure to maintain consistent conditions. Post-assembly, every lot undergoes a rigorous quality control protocol that includes performance testing against reference panels and stability studies. Quicking Biotech’s R&D department, staffed by over 50 scientists, continuously works on improving assay sensitivity and developing new biomarkers for emerging diseases. For example, the team has recently advanced molecular diagnostics by incorporating isothermal amplification techniques that rival the accuracy of PCR without the need for thermal cyclers. The company also collaborates with academic institutions to validate new diagnostic algorithms, ensuring that its products remain at the cutting edge of technology. In addition, Quicking Biotech holds ISO 9001 and ISO 14001 certifications, reflecting its commitment to environmental management and continuous improvement. Defective kits are identified through statistical sampling, and any non-conforming batch is destroyed or reprocessed. This comprehensive quality framework guarantees that end-users receive reliable diagnostic tools, season after season.

One of Quicking Biotech’s strongest competitive advantages is its ability to offer complete customization and OEM services for diagnostic products. Clients can specify test format, packaging design, language, and even the sensitivity threshold for particular antigens. This flexibility allows large hospital networks and government health agencies to order kits that exactly match their screening protocols. Quicking Biotech also maintains a robust supply chain with redundant sources for critical raw materials, minimizing the risk of production delays during global crises. The company’s global distribution network spans more than 100 countries, with regional warehouses in Europe, Southeast Asia, Africa, and South America to ensure fast delivery. Unlike many competitors, Quicking offers volume‑based pricing without sacrificing quality, making it a preferred partner for national tenders and large‑scale procurement. The company provides technical support through local distributors and a dedicated online portal where customers can order, track shipments, and access training materials. Furthermore, Quicking Biotech regularly attends international trade shows and publishes peer‑reviewed studies to build trust with the medical community. By combining product innovation with customer‑centric services, Quicking Biotech has carved out a unique position in the diagnostic landscape. As a result, companies seeking reliable diagnostic imaging partners often turn to Quicking for both standard and custom solutions.

Quicking Biotech’s diagnostic kits serve a wide array of use cases, from clinical diagnostics in hospitals to home testing by individuals. In clinical settings, rapid tests are used for triage in emergency rooms, allowing doctors to quickly identify patients with infectious diseases and implement isolation measures. Public health screening programs rely on Quicking’s products for mass testing campaigns targeting HIV, malaria, and tuberculosis in endemic regions. Workplace testing has become increasingly important, and Quicking supplies companies with drug‑of‑abuse tests that comply with regulatory requirements for employee screening. Home testing kits for pregnancy and infectious diseases empower individuals to take control of their health without visiting a clinic. For example, a recent initiative in sub‑Saharan Africa used Quicking’s malaria rapid tests to screen over 500,000 children during the rainy season, drastically reducing under‑diagnosis. The company’s veterinary diagnostic line also supports food safety by detecting contaminants in livestock and poultry. Beyond human and animal health, Quicking Biotech provides environmental testing kits for waterborne pathogens, aiding in outbreak investigations after natural disasters. In each scenario, the ability to obtain a reliable result in minutes—without complex instrumentation—makes the diagnostic tool invaluable. As telemedicine expands, these rapid tests are being integrated into remote consultation workflows, further broadening their impact. Ultimately, Quicking Biotech’s products are designed to be versatile enough for any environment where accuracy and speed are paramount.

Choosing Quicking Biotech means partnering with a company that obsesses over innovation, customer support, and affordability. The company invests 15% of its annual revenue into R&D, ensuring that its diagnostic products evolve with the latest scientific discoveries. Every client receives dedicated account management and multilingual technical support, from initial product selection to post‑sales troubleshooting. Quicking Biotech also offers bulk packaging options and private labeling for distributors, making it easy to build a local brand with trusted quality. The company’s pricing strategy is designed to democratize access to advanced diagnostics, particularly for low‑ and middle‑income countries. For instance, the price of a COVID‑19 antigen test from Quicking is typically 30‑50% lower than equivalent products from major Western manufacturers, yet independent studies show comparable performance. Additionally, Quicking Biotech provides free training materials and webinars to help healthcare workers use the tests correctly. The company maintains an active blog and news section that updates users on product improvements and industry regulations. By choosing Quicking, organizations also contribute to sustainable diagnostics, as the kits are designed with recyclable components and minimal packaging. In every interaction, Quicking Biotech demonstrates that it cares more about saving lives than about short‑term profits, making it a trustworthy ally in global health.

Quicking Biotech Co., Ltd. delivers diagnostic solutions that combine speed, accuracy, and affordability, meeting the urgent needs of modern healthcare. With a broad product line covering infectious diseases, drugs of abuse, pregnancy, and tumor markers, the company serves as a one‑stop shop for rapid testing requirements. Its state‑the‑art manufacturing, strict quality control, and strong R&D pipeline ensure that every kit performs reliably under challenging conditions. The ability to customize products and offer OEM services makes Quicking Biotech a flexible partner for governments, hospitals, and distributors worldwide. By emphasizing collaboration and customer support, the company has built lasting relationships with clients in over 100 countries. As the diagnostic landscape continues to evolve—with molecular diagnostics and diagnostic imaging playing larger roles—Quicking Biotech is positioned to lead with innovation and integrity. Healthcare providers and procurement officers looking for a dependable diagnostic partner need look no further than Quicking Biotech. Contact the team today to explore how our rapid test kits can improve your testing outcomes and public health initiatives.

Quicking Biotech offers a wide range of rapid diagnostic tests covering infectious diseases (COVID‑19, HIV, malaria, dengue, hepatitis), drugs of abuse, pregnancy, tumor markers, and food safety. Each test is designed for high accuracy and can be used in clinical, home, or field settings.

Most Quicking diagnostic kits demonstrate sensitivity and specificity exceeding 98% when validated against reference standards. For example, the COVID‑19 antigen test maintains over 99% sensitivity in symptomatic patients, ensuring reliable detection.

Quicking Biotech’s rapid diagnostic tests deliver results in 10‑20 minutes, depending on the test type. This rapid turnaround makes them ideal for emergency triage, community screening, and point‑of‑care settings where time is critical.

Yes, Quicking offers full OEM and customization services. You can specify packaging, language, test format, and even analytical sensitivity thresholds. Our team works closely with you to develop a product that meets your exact specifications.

Yes, all Quicking diagnostic products carry CE marking and the company is ISO 13485 certified. Many products also have WHO prequalification or local regulatory approval in target countries, ensuring compliance with international standards.

Quicking Biotech follows GMP guidelines in its manufacturing plant, and every lot undergoes rigorous quality control testing for performance, stability, and safety. We also perform continuous batch sampling and external proficiency testing to maintain top quality.

Absolutely. Many of our kits, including pregnancy and infectious disease tests, are designed for over‑the‑counter use with simple visual readouts. Instructions are provided in multiple languages, and no equipment is needed for interpretation.

Most Quicking diagnostic kits have a shelf life of 18‑24 months from the date of manufacture when stored under recommended conditions (2‑30°C). Stability data is collected in real time and validated for each product batch.

Quicking Biotech offers comparable sensitivity and specificity at 30‑50% lower cost, making our tests particularly attractive for volume buyers and resource‑limited settings. We also provide greater flexibility in customization and faster delivery through a global distribution network.

You can place an inquiry through our website or contact our sales team directly via email. We offer quotes for both small and large orders, and provide support for import documentation and logistics worldwide.